Business Context and Reporting Period
Company: Jefferson Capital, Inc. (JCAP)
Filing Type: Form 8-K (Current Report)
Date of Report: October 24, 2025
Reporting Period: Events occurring on October 24, 2025, and announced October 27, 2025.
The Company, an emerging growth company, reported the entry into a Material Definitive Agreement to acquire a credit card receivables portfolio and the amendment of its existing credit facility.
Key Financial Metrics and Transaction Details
Asset Purchase Agreement
- Target: Credit card receivables portfolio from Bluestem (Sellers).
- Gross Purchase Price: $302.8 million (subject to customary adjustments).
- Escrow: $20.0 million to secure implementation obligations.
- Asset Face Value: Approximately $488.2 million as of the June 30, 2025 Cut Off Date.
- Asset Status: Revolving portfolio with new draws suspended; includes related IP, books, records, and bank accounts.
- Servicing: To be transitioned to CardWorks Servicing, LLC.
- Closing Timeline: Expected in the fourth quarter of 2025, subject to HSR Act waiting period.
Amended Credit Agreement
- Aggregate Commitments: Increased by $175.0 million to a total of $1.0 billion.
- Interest Rate Margins: Reduced by 50 basis points.
- Non-Use Fees: Reduced by 5 basis points; maximum rate capped at 35 basis points.
- Spread Adjustments: Credit spread adjustments eliminated.
- Maturity Date: Extended to October 27, 2030 (subject to reduction to 91 days prior to the earliest maturity of specific Senior Notes).
- Covenants: Minimum tangible net worth covenant removed; permitted restricted payments modified to allow for tax payments, note redemptions, and dividends (capped at the greater of 6% of market cap or specified quarterly amount).
Material Changes Versus Prior Period
This filing represents a significant expansion of the Company's asset base and liquidity capacity compared to prior periods:
- Asset Acquisition: The Company is acquiring a $488.2 million face value portfolio, marking a strategic entry into a specific credit card receivables segment without ongoing originations.
- Debt Capacity: The credit facility size increased by 21% (from $825 million to $1.0 billion).
- Cost of Capital: Borrowing costs were reduced through margin cuts and the elimination of credit spread adjustments.
- Liquidity Flexibility: The removal of the tangible net worth covenant and the extension of the maturity date provide greater operational flexibility.
Guidance, Outlook, and Risks
Management Commentary and Strategy: The Company explicitly stated it does not intend to pursue ongoing originations through the Bluestem platform. The transaction is structured as an asset purchase of a suspended portfolio, focusing on collection and servicing rather than new lending.
Risks and Contingencies:
- Closing Conditions: The asset purchase is subject to customary conditions, including the expiration of the Hart-Scott-Rodino Antitrust Improvements Act waiting period.
- Adjustments: The final purchase price is subject to adjustments for interim cash flows (collections and new purchases) between June 30, 2025, and the closing date.
- Debt Maturity: The credit facility maturity is contingent on the maturity dates of the Company's Senior Notes (due 2029 and 2030).
Financial Metrics: The filing text does not provide current revenue, profit, cash flow, or margin figures for the Company as a whole, as this is a transactional 8-K filing rather than a periodic financial report.
Investor Verification Checklist
- Transaction Closing: Verify the actual closing date and final purchase price adjustments in the Q3 2025 Form 10-Q.
- Asset Quality: Review the specific delinquency rates and vintage of the $488.2 million receivables portfolio in the full Asset Purchase Agreement.
- Debt Utilization: Monitor the utilization rate of the new $1.0 billion credit facility and the impact of the 50 basis point margin reduction on interest expense.
- Regulatory Approval: Confirm the expiration of the HSR waiting period to ensure the transaction proceeds as scheduled in Q4 2025.
- Dividend Policy: Assess the impact of the new restricted payment terms on the Company's ability to fund quarterly dividends relative to its market capitalization.